Finch Therapeutics Group, Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Finch Therapeutics Group, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2023.
  • Finch Therapeutics Group, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.28M, a 56.5% decline year-over-year.
  • Finch Therapeutics Group, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $5.34M, a 36.5% increase year-over-year.
  • Finch Therapeutics Group, Inc. annual Nonoperating Income (Expense) for 2023 was $5.65M, a 496% increase from 2022.
  • Finch Therapeutics Group, Inc. annual Nonoperating Income (Expense) for 2022 was $947K, a 48.1% decline from 2021.
  • Finch Therapeutics Group, Inc. annual Nonoperating Income (Expense) for 2021 was $1.83M, a 1821% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.65M +$4.7M +496% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 $947K -$878K -48.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 $1.83M +$1.73M +1821% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $95K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.